| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |